In addition, whole-exome sequencing identified that PCK2 was associated with cancer cell proliferation in patients with hepatocellular carcinoma12, but there are few further studies on the molecular mechanism of PCK2, especially its correlation with clinical prognosis, metastasis, and immunity, which needs to be further confirmed. The gene discussed is PCK2; the disease is cancer.